D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$354M |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$309M |
| 3 |
Microsoft
MSFT
|
+$307M |
| 4 |
Automatic Data Processing
ADP
|
+$266M |
| 5 |
Citigroup
C
|
+$251M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
APC
Anadarko Petroleum
APC
|
+$567M |
| 2 |
Fidelity National Information Services
FIS
|
+$410M |
| 3 |
Medtronic
MDT
|
+$359M |
| 4 |
Amazon
AMZN
|
+$297M |
| 5 |
ATVI
Activision Blizzard
ATVI
|
+$272M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.59% |
| 2 | Consumer Discretionary | 12.73% |
| 3 | Healthcare | 11.62% |
| 4 | Financials | 8.02% |
| 5 | Industrials | 6.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3276
Cal-Maine
CALM
$4.28B
| $393K | ﹤0.01% |
9,833
-28,105
| -74% | -$1.17M |
|
|
CLVS
3277
PUT
DELISTED
Clovis Oncology, Inc.
CLVS
| $393K | ﹤0.01% |
100,000
+87,600
| +706% | +$709K |
|
3278
Antero Resources
AR
$10.9B
| $388K | ﹤0.01% |
128,642
+71,517
| +125% | +$291K |
|
|
PLAN
3279
CALL
DELISTED
Anaplan, Inc.
PLAN
| $385K | ﹤0.01% |
+8,200
| New | +$445K |
|
3280
Wave Life Sciences
WVE
$1.12B
| $384K | ﹤0.01% |
18,690
-67,289
| -78% | -$1.54M |
|
3281
Northwest Natural Holdings
NWN
$2.17B
| $383K | ﹤0.01% |
+5,373
| New | +$381K |
|
|
MRSN
3282
DELISTED
Mersana Therapeutics
MRSN
| $382K | ﹤0.01% |
9,663
-130
| -1% | -$9.45K |
|
3283
Cohen & Steers
CNS
$4.18B
| $381K | ﹤0.01% |
6,933
-789
| -10% | -$41.8K |
|
|
TIVO
3284
PUT
DELISTED
Tivo Inc
TIVO
| $381K | ﹤0.01% |
50,000
| – | – |
|
3285
CALL
B&G Foods
BGS
$285M
| $378K | ﹤0.01% |
+20,000
| New | +$384K |
|
3286
CALL
Chemours
CC
$2.59B
| $378K | ﹤0.01% |
25,300
-13,900
| -35% | -$226K |
|
3287
Newell Brands
NWL
$2.16B
| $378K | ﹤0.01% |
20,200
-992,407
| -98% | -$16M |
|
3288
Nexstar Media Group
NXST
$5.6B
| $378K | ﹤0.01% |
+3,696
| New | +$374K |
|
|
STEL
3289
DELISTED
Stellar Bancorp
STEL
| $377K | ﹤0.01% |
13,515
-10,426
| -44% | -$297K |
|
|
GTT
3290
PUT
DELISTED
GTT Communications, Inc.
GTT
| $377K | ﹤0.01% |
+40,000
| New | +$450K |
|
|
UFS
3291
DELISTED
DOMTAR CORPORATION (New)
UFS
| $377K | ﹤0.01% |
10,533
-9,417
| -47% | -$350K |
|
3292
Atlanta Braves Holdings Series A
BATRA
$3.53B
| $376K | ﹤0.01% |
13,494
+1,288
| +11% | +$36.4K |
|
3293
VSE Corp
VSEC
$5.48B
| $375K | ﹤0.01% |
10,986
+1,173
| +12% | +$35.6K |
|
|
SCPL
3294
DELISTED
SciPlay Corporation Class A Common Stock
SCPL
| $375K | ﹤0.01% |
35,073
-9,997
| -22% | -$109K |
|
3295
PUT
Equity Lifestyle Properties
ELS
$12.8B
| $374K | ﹤0.01% |
+5,600
| New | +$365K |
|
3296
Winmark
WINA
$1.19B
| $374K | ﹤0.01% |
2,119
+16
| +0.8% | +$2.7K |
|
|
ARC
3297
DELISTED
ARC Document Solutions, Inc.
ARC
| $373K | ﹤0.01% |
273,919
| – | – |
|
3298
CALL
Kratos Defense & Security Solutions
KTOS
$8.88B
| $372K | ﹤0.01% |
+20,000
| New | +$420K |
|
|
LDL
3299
DELISTED
Lydall, Inc.
LDL
| $372K | ﹤0.01% |
14,934
-22,654
| -60% | -$484K |
|
3300
CALL
National Health Investors
NHI
$3.9B
| $371K | ﹤0.01% |
4,500
-9,700
| -68% | -$789K |
|
Similar funds
D.E. Shaw & Co's Q3 2019 Portfolio in Review
As of Q3 2019, D.E. Shaw & Co held 4,189 positions worth $81.2B, up 1.3% from $80.2B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
D.E. Shaw & Co's Q3 2019 filing shows 550 new, 1,503 increased, 1,391 reduced and 422 closed positions. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 3,554,658 shares worth $310M. The largest sale was Anadarko Petroleum, an estimated $567M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- D.E. Shaw & Co's largest Q3 2019 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 3,554,658 shares worth $310M.
- D.E. Shaw & Co added most to PayPal in Q3 2019, an estimated $354M increase.
- D.E. Shaw & Co's biggest Q3 2019 reduction was Fidelity National Information Services, cutting an estimated $410M.
- D.E. Shaw & Co fully exited Anadarko Petroleum in Q3 2019, selling an estimated $567M.
- D.E. Shaw & Co's ten largest holdings make up 10% of its $81.2B portfolio in Q3 2019.
- D.E. Shaw & Co opened 550 new positions and closed 422 in Q3 2019.
- D.E. Shaw & Co's portfolio value rose 1.3% quarter-over-quarter to $81.2B.
Based on D.E. Shaw & Co's 13F filing for Q3 2019, filed 14 Nov 2019.